|1.||Doi, Adriana M: 1 article (06/2007)|
|2.||Hill, Georgette: 1 article (06/2007)|
|3.||Hailey, James R: 1 article (06/2007)|
|4.||Seely, John: 1 article (06/2007)|
|5.||Kissling, Grace: 1 article (06/2007)|
|6.||Bucher, John R: 1 article (06/2007)|
|7.||Papadimitriou, Dimitrios K: 1 article (01/2007)|
|8.||Tachtsi, Maria D: 1 article (01/2007)|
|9.||Kalaitzis, Eustratios D: 1 article (01/2007)|
|10.||Pitoulias, Georgios A: 1 article (01/2007)|
01/01/2005 - "Under the conditions of these studies, there was clear evidence of carcinogenic activity of decalin in male F344/N rats based on increased incidences of renal tubule neoplasms. "
06/01/2007 - "NTP studies with decalin, propylene glycol mono-t-butyl ether and Stoddard solvent IIC included extended evaluations of alpha(2u)-related nephropathy, and were thus used in assessing the linkage between key events in 90-day studies with renal tumors in 2-year studies. "
|2.||Psoriasis (Pustulosis Palmaris et Plantaris)
12/01/2001 - "This study aimed to prove the similarity of the composition of non-aromatic Croatian naphthalane (NAN) with brown naphthalane (BN), which is used in the treatment of psoriasis vulgaris. "
12/01/2001 - "Non-aromatic naphthalane preparation; preliminary clinical study in the treatment of psoriasis vulgaris."
08/01/2005 - "In spite of the fact that noncolored (nonaromatic) naphthalane containing high sterane content has been proved as bioactive and efficient in the treatment of psoriasis vulgaris, brown naphthalanes, which contain aromatics, are still in use. "
05/18/2001 - "Non-aromatic Croatian naphthalane (NAN), shown to be efficace in the treatment of psoriasis vulgaris, was studied in order to improve our understanding of its constituents, which may be potentially responsible for its bioactivity. "
12/01/2004 - "The aim of this study was to evaluate the effectiveness of oxygenated F-Decalin on the intestinal viability, in an experimental model of acute intestinal ischemia. "
01/01/2007 - "Thirty-six rabbits were separated into three groups: (a) Control group (ischemia alone), (b) PFC-O2 group (ischemia plus infusion of oxygenated F-Decalin in intraluminal intestinal administration), and (c) PFC group (ischemia plus infusion of nonoxygenated F-Decalin in intraluminal intestinal administration). "
12/01/2004 - "The animals were divided into three groups: (a) Control (ischemia alone), (b) PFC-O2 (ischemia plus infusion of oxygenated F-Decalin) and (c) PFC (ischemia plus infusion of not-oxygenated F-Decalin). "
|4.||Body Weight (Weight, Body)
01/01/1987 - "Decalin (in corn oil vehicle) was administered at doses of 0, 0.1, 0.5, 1.0 or 2.0 g/kg body weight to male rats, and 0, 1.0, 1.5, 1.75 or 2.0 g/kg to female rats. "
05/01/1987 - "Groups of young adult male Fischer-344 rats given the vehicle (corn oil) or either decalin or d-limonene at dose levels of 75, 150 or 300 mg/kg body weight by a single daily gavage on 5 days/wk were killed on study days 6 or 27, approximately 24 hr after the fifth or 20th dose, to determine whether the specific time- and dose-related triad of renal alterations characterizing decalin-associated nephrotoxicity in the adult male rat also occurs in response to d-limonene. "
02/01/1992 - "A total of 67 patients with obliterating atherosclerosis of the vessels of low extremities were followed up in the treatment at the Naphthalane health resort. "
02/01/1992 - "[State of hemostasis during naphthalane treatment of patients with obliterating atherosclerosis of the vessels of the lower limbs]."
06/01/1991 - "[Changes in the phase structure of the left ventricle systole in patients with obliterative atherosclerosis of the lower extremities after treatment with naphthalane baths]."
|1.||Corn Oil (Oil, Corn)
|2.||propylene glycol mono-t-butyl ether
|6.||Petroleum (Crude Oil)
|9.||alpha 2u globulin